Five-Year Sustained Durability of Clinical Response After Gastric Electrical Stimulation Therapy (GES) for Severe Gastroparesis

2014 ◽  
Vol 109 ◽  
pp. S53-S54
Author(s):  
Anam Hameed ◽  
John Stroehlein ◽  
Mehnaz Shafi
2013 ◽  
Vol 144 (5) ◽  
pp. S-120
Author(s):  
Archana Kedar ◽  
Harsha S. Nagarajarao ◽  
Yana Nikitina ◽  
Vetta Vedanarayanan ◽  
Christopher J. Lahr ◽  
...  

2014 ◽  
Vol 146 (5) ◽  
pp. S-267 ◽  
Author(s):  
Endashaw Omer ◽  
Lindsay McElmurray ◽  
Archana Kedar ◽  
Michael G. Hughes ◽  
Robert Cacchione ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-516
Author(s):  
Irene Sarosiek ◽  
Brian R. Davis ◽  
Yvette Gomez ◽  
Jerzy Sarosiek ◽  
Richard W. McCallum

Endoscopy ◽  
2020 ◽  
Vol 52 (05) ◽  
pp. 349-358 ◽  
Author(s):  
Shanshan Shen ◽  
Hui Luo ◽  
Cicily Vachaparambil ◽  
Parit Mekaroonkamol ◽  
Mohamed M. Abdelfatah ◽  
...  

Background Gastric peroral endoscopic pyloromyotomy (G-POEM) and gastric electrical stimulation (GES) have been reported as treatment options for refractory gastroparesis. In this study, we compared the long term clinical outcomes of G-POEM versus GES in the treatment of such patients. Methods We retrospectively evaluated 111 consecutive patients with refractory gastroparesis between January 2009 and August 2018. To overcome selection bias, we used propensity score matching (1:1) between G-POEM and GES treatment. The primary outcome was the duration of clinical response. Results After propensity score matching, 23 patients were included in each group. After a median follow-up of 27.7 months, G-POEM had a significantly better and longer clinical response than GES (hazard ratio [HR] for clinical recurrence 0.39, 95 % confidence interval [CI] 0.16 – 0.95; P = 0.04). The median duration of response was 25.4 months (95 %CI 8.7 – 42.0) in the GES group and was not reached in the G-POEM group. The Kaplan – Meier estimate of 24-month clinical response rate was 76.6 % with G-POEM vs. 53.7 % with GES. GES appeared to have little effect on idiopathic gastroparesis (HR for recurrence with G-POEM vs. GES 0.35, 95 %CI 0.13 – 0.95; P = 0.05). The incidence of adverse events was higher in the GES group (26.1 % vs. 4.3 %; P = 0.10). Conclusion Among patients with refractory gastroparesis, clinical response was better and lasted longer with G-POEM than with GES. The positive outcomes with G-POEM are likely to derive from the superior clinical response in patients with idiopathic gastroparesis. Further studies are needed to confirm these findings.


2005 ◽  
Vol 3 (1) ◽  
pp. 49-54 ◽  
Author(s):  
Richard McCallum ◽  
Zhiyue Lin ◽  
Paul Wetzel ◽  
Irene Sarosiek ◽  
Jameson Forster

Sign in / Sign up

Export Citation Format

Share Document